Literature DB >> 16918893

Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database.

R Jones1, R Latinovic, J Charlton, M Gulliford.   

Abstract

BACKGROUND: Irritable bowel syndrome is a common problem known to have a complex relationship with psychological disorders and other physical symptoms. Little information, however, is available concerning physical and psychological comorbidity in irritable bowel syndrome patients studied over an extended period. AIM: To evaluate physical and psychological morbidity 2 years before and during 6 years after the time of diagnosis in incident cases of irritable bowel syndrome and control subjects.
METHODS: A matched cohort study was implemented in 123 general practices using the General Practice Research Database. Irritable bowel syndrome cases (n = 1827) and controls (n = 3654) were compared for 2 years before and 6 years after diagnosis.
RESULTS: The age-standardized incidence of irritable bowel syndrome in patients over 15 years of age was 1.9 per 1,000 in men and 5.8 per 1,000 in women. From 2 years before the date of diagnosis, more irritable bowel syndrome cases (13%) than controls (5%) consulted with depression or were prescribed antidepressant drugs. Consultation and prescription rates for anxiety were also higher before diagnosis, and both anxiety and depression remained prevalent up to 6 years after diagnosis. Asthma, symptoms of urinary tract infection, gall-bladder surgery, hysterectomy and diverticular disease were recorded more frequently in irritable bowel syndrome patients, who were also more likely than controls to be referred to hospital.
CONCLUSIONS: People who are diagnosed with irritable bowel syndrome experience more anxiety and depression and a range of physical problems, compared with controls; they are more likely to be referred to hospital.

Entities:  

Mesh:

Year:  2006        PMID: 16918893     DOI: 10.1111/j.1365-2036.2006.03044.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  21 in total

Review 1.  Psychological approach to managing irritable bowel syndrome.

Authors:  Bu'Hussain Hayee; Ian Forgacs
Journal:  BMJ       Date:  2007-05-26

Review 2.  Management of diverticular disease.

Authors:  Roland H Pfützer; Wolfgang Kruis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-07-14       Impact factor: 46.802

3.  The CPRD and the RCGP: building on research success by enhancing benefits for patients and practices.

Authors:  Antonis A Kousoulis; Imran Rafi; Simon de Lusignan
Journal:  Br J Gen Pract       Date:  2015-02       Impact factor: 5.386

4.  The gut microbiota and psychiatric illness.

Authors:  Glenda MacQueen; Michael Surette; Paul Moayyedi
Journal:  J Psychiatry Neurosci       Date:  2017-03       Impact factor: 6.186

Review 5.  The mucosal immune system: master regulator of bidirectional gut-brain communications.

Authors:  Nick Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-18       Impact factor: 46.802

6.  Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns.

Authors:  Elisa Martín-Merino; Ana Ruigómez; Saga Johansson; Mari-Ann Wallander; Luis A García-Rodriguez
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

7.  Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress.

Authors:  L S Savas; D L White; M Wieman; K Daci; S Fitzgerald; S Laday Smith; G Tan; D P Graham; J A Cully; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2008-09-09       Impact factor: 8.171

8.  Irritable bowel syndrome symptoms and health related quality of life in female veterans.

Authors:  D P Graham; L Savas; D White; R El-Serag; S Laday-Smith; G Tan; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2009-10-08       Impact factor: 8.171

9.  The role of colonic mast cells and myenteric plexitis in patients with diverticular disease.

Authors:  Gabrio Bassotti; Vincenzo Villanacci; Riccardo Nascimbeni; Elisabetta Antonelli; Moris Cadei; Stefania Manenti; Luisa Lorenzi; Amin Titi; Bruno Salerni
Journal:  Int J Colorectal Dis       Date:  2012-08-05       Impact factor: 2.571

10.  Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link?

Authors:  Ana Ruigómez; Mari-Ann Wallander; Saga Johansson; Luis Alberto García Rodríguez
Journal:  Dig Dis Sci       Date:  2008-08-22       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.